Sheep Polyclonal ST6GAL2 antibody. Suitable for WB and reacts with Human samples. Immunogen corresponding to Recombinant Fragment Protein within Human ST6GAL2 aa 200-550.
View Alternative Names
KIAA1877, SIAT2, ST6GAL2, ST6Gal II, Sialyltransferase 2, ST6GalII, hST6Gal II
- WB
Supplier Data
Western blot - Anti-ST6GAL2 antibody (AB214920)
All lanes:
Western blot - Anti-ST6GAL2 antibody (ab214920) at 1/1000 dilution
All lanes:
Human brain tissue lysate
Predicted band size: 60 kDa
false
Reactivity data
Properties and storage information
Form
Reconstitution
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The enzyme plays an integral role in the sialylation of glycan structures influencing cellular interactions and signaling pathways. It does not generally function as a component of a larger complex but works independently in modifying glycoproteins which are important for cell surface interactions neural development and immune response. The sialylation impacts the recognition and binding abilities of glycosylated molecules affecting both intra- and inter-cellular communication.
Pathways
This enzyme is vital in the sialylation branch of the glycosylation pathway which is important in the synthesis of complex carbohydrates on cell surfaces. This pathway intersects with insulin signaling where glycoproteins engage in regulatory feedback mechanisms. ST6GAL2 also relates to the immune response pathways where its activity modifies the surface antigens therefore impacting interactions with immune receptors.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com